checkAd

    Media Release  101  0 Kommentare Sensirion product announcement: miniature liquid flow sensor platform for subcutaneous drug delivery

    Für Sie zusammengefasst
    • Sensirion announces miniature liquid flow sensor platform for subcutaneous drug delivery.
    • SLD3x series improves dosing accuracy and patient safety in subcutaneous therapies.
    • Customizable solutions for various therapies, with flow rates from 100 µl/min to 5 ml/min.

    Sensirion Holding AG / Key word(s): Miscellaneous
    Media Release: Sensirion product announcement: miniature liquid flow sensor platform for subcutaneous drug delivery

    08.05.2024 / 08:08 CET/CEST


    Media Release

    08.05.2024, Sensirion AG, 8712 Stäfa, Schweiz

     

    Sensirion product announcement: miniature liquid flow sensor platform for subcutaneous drug delivery

    In the changing landscape of the healthcare industry, Sensirion's SLD3x series contributes to the improvement of subcutaneous drug delivery with miniature, and highly accurate digital liquid flow sensors. Customizable solutions ensure optimal dosing and enhanced patient safety for various subcutaneous therapies.

    Stäfa, Switzerland – The healthcare industry has undergone a significant transformation in recent years, with an increasing focus on patient and home care. This shift has been mirrored in the field of drug administration, with a decrease in hospital stays for certain treatments. The transition from intravenous to subcutaneous injections using large volume injectors (LVIs) has been a key driver of this change.

    LVIs are wearable devices that enable continuous subcutaneous drug delivery. They reduce pressure on clinical staff, save costs, and improve patient comfort. Some LVIs require precise dosing of the delivered drug, which in turn requires the pump to be controlled by a flow sensor. Moreover, bubbles, empty lines, occlusion detection, and drug delivery confirmation are desirable to improve patient safety and the regulatory compliance of the device.

    To meet these needs, Sensirion is developing the SLD3x platform – a series of digital liquid flow sensors to combine accurate flow measurement, miniature size, and compatibility with several therapies. This makes it the ideal solution for medical devices manufactured in large quantities, where an accurate, disposable liquid flow sensor is required. While flow measurement is at the heart of the SLD3x platform, it also provides a stream of data that can be used to detect occlusions, identify in-line air bubbles, flag up pump malfunctions and measure liquid temperature.

    Seite 1 von 3



    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    Media Release Sensirion product announcement: miniature liquid flow sensor platform for subcutaneous drug delivery Sensirion Holding AG / Key word(s): Miscellaneous Media Release: Sensirion product announcement: miniature liquid flow sensor platform for subcutaneous drug delivery 08.05.2024 / 08:08 CET/CEST Media Release 08.05.2024, Sensirion AG, 8712 Stäfa, …